Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Edwin Mejia Ortega

Nurse Practitioner, Pediatrics Orlando, FL Nurse Practitioner

NPI 1164909149 CMS profile 10468270

60 W Gore St, Orlando, FL 32806

Open in the dashboard

General payments

$14,252

197 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edwin Mejia Ortega of Orlando, FL is reported in the CMS Open Payments database as having received $14,252 across 197 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,089 65
2024 General $2,124 53
2023 General $7,940 56
2022 General $739 18
2021 General $360 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edwin Mejia Ortega
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Edwin Mejia Ortega were reported at $3,089. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Edwin Mejia Ortega Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $360 $60 $23–$142 $132
2022 $739 $72 $27–$161 $149
2023 $7,940 $89 $35–$185 $160
2024 $2,124 $93 $34–$199 $164
2025 $3,089 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Kyowa Kirin, Inc. $3,997 24 payments
  2. Medtronic, Inc. $3,955 20 payments
  3. Genzyme Corporation $1,150 2 payments
  4. Insulet Corporation $936 30 payments
  5. Ascendis Pharma, Inc. $544 17 payments
  6. Novo Nordisk Inc $520 10 payments
  7. Sanofi-Aventis U.S. LLC $514 10 payments
  8. Tandem Diabetes Care, Inc. $435 15 payments
  9. Beta Bionics, Inc. $283 8 payments
  10. Tolmar, Inc. $266 7 payments
  11. Other $1,653 54 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,942 186 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,260 4 payments
  3. Travel and Lodging $1,050 6 payments
  4. Consulting Fee $1,000 1 payment
Products named General payments · program years 2021–2025
  1. Crysvita fibroblast growth factor 23 (FGF23) blocking antibody. $3,583 18 payments
  2. MINIMED 780G $2,233 7 payments
  3. TZIELD $1,519 11 payments
  4. MINIMED 770G $1,406 4 payments
  5. Omnipod $936 30 payments
  6. Sogroya $520 10 payments
  7. SKYTROFA $515 16 payments
  8. t:slim X2 Insulin Pump with Control-IQ $331 14 payments
  9. CRYSVITA Fibroblast Growth Factor 23 Fgf23 Blocking Antibody $285 5 payments
  10. iLet Bionic Pancreas $233 6 payments
  11. Other $3,151 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

197 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record